The EXOSC7 antibody is a research tool designed to detect the EXOSC7 protein, a critical component of the human exosome complex. The exosome, a multi-subunit ribonuclease complex, plays a central role in RNA processing, degradation, and quality control. EXOSC7 (Exosome Component 7), also known as Rrp42. forms part of the exosome's structural core and contributes to its 3'→5' exoribonuclease activity, essential for regulating diverse RNA species, including rRNA, snoRNA, and mRNA.
Antibodies targeting EXOSC7 are widely used to study its expression, localization, and interactions in cellular contexts. They enable techniques like Western blotting, immunofluorescence, and immunoprecipitation, aiding investigations into RNA metabolism, gene expression regulation, and exosome dysfunction. Dysregulation of EXOSC7 has been linked to neurological disorders, such as pontocerebellar hypoplasia, and cancer, where aberrant RNA processing drives pathogenesis.
These antibodies are critical for validating EXOSC7 knockout/knockdown models and assessing clinical samples for diagnostic or therapeutic applications. Researchers often verify antibody specificity using siRNA-mediated protein depletion or recombinant EXOSC7 controls. Commercial EXOSC7 antibodies are typically raised in hosts like rabbits or mice, with validation data provided for specific applications. Understanding EXOSC7's role through such antibodies advances insights into RNA biology and disease mechanisms.